Bristol Myers Squibb aligns UK and US prices for new schizophrenia drug

All NewsSeptember 22, 2025

Pharmaceutical companies are under pressure to lower prices on both sides of the Atlantic

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent